Methylphenidate HCL ER
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- SPE2D219R0044
- Agency
- Medical Supply Chain Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
The Federal Contract Opportunity is for the supply of Methylphenidate HCL ER in 10MG and 20MG quantities, with an estimated quantity of 6,576 and 13,293 bottles respectively. The contract includes a base year and four option years. The contract also requires the contractor to comply with various FAR clauses, maintain their Commercial and Government Entity (CAGE) code, and adhere to the terms of the contract, including potential extension.
List of products and services to be provided:
- Methylphenidate HCL ER 10MG - 100 Count
- Methylphenidate HCL ER 20MG - 100 Count
- Compliance with FAR clauses
- Maintenance of CAGE code
- Adherence to contract terms and potential extension.
Notice text
8 versions
Update #8 · Latest ·
Modification P00007 SPE2D220D0085 to exercise Option Year 4.
Modification SPE2D220D0085 P00006 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract.
Modification SPE2D220D0085 P00005 to incorporate clause FAR 52.204-27 Prohibition on a ByteDance Covered Application (JUN 2023) into subject contract.
Modification P00004 SPE2D220D0085 to exercise Option 3.
Modification P00003 SPE2D220D0085 to exercise Option 2.
Modification P00002 SPE2D220D0085 to exercise Option 1.
Modification P00001 SPE2D220D0085 to incorporate FAR 52.204-24 and FAR 52.204-25 into contract.
Methylphenidate HCL ER
Update #7 ·
Modification SPE2D220D0085 P00006 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract.
Modification SPE2D220D0085 P00005 to incorporate clause FAR 52.204-27 Prohibition on a ByteDance Covered Application (JUN 2023) into subject contract.
Modification P00004 SPE2D220D0085 to exercise Option 3.
Modification P00003 SPE2D220D0085 to exercise Option 2.
Modification P00002 SPE2D220D0085 to exercise Option 1.
Modification P00001 SPE2D220D0085 to incorporate FAR 52.204-24 and FAR 52.204-25 into contract.
Methylphenidate HCL ER
Update #6 ·
Modification P00004 SPE2D220D0085 to exercise Option 3.
Modification P00003 SPE2D220D0085 to exercise Option 2.
Modification P00002 SPE2D220D0085 to exercise Option 1.
Modification P00001 SPE2D220D0085 to incorporate FAR 52.204-24 and FAR 52.204-25 into contract.
Methylphenidate HCL ER
Update #5 ·
Modification P00003 SPE2D220D0085 to exercise Option 2.
Modification P00002 SPE2D220D0085 to exercise Option 1.
Modification P00001 SPE2D220D0085 to incorporate FAR 52.204-24 and FAR 52.204-25 into contract.
Methylphenidate HCL ER
Update #4 ·
Modification P00002 SPE2D220D0085 to exercise Option 1.
Modification P00001 SPE2D220D0085 to incorporate FAR 52.204-24 and FAR 52.204-25 into contract.
Methylphenidate HCL ER
Update #3 ·
Modification P00001 SPE2D220D0085 to incorporate FAR 52.204-24 and FAR 52.204-25 into contract.
Methylphenidate HCL ER
Update #2 ·
Methylphenidate HCL ER
Update #1 ·
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Methylphenidate HCL ER. Procurement details follow.
Methylphenidate HCL ER 10MG and 20MG in 100 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and FEDBIZOPS at https://www.fbo.gov. Interested parties should contact Ryan Ferry (215-737-3182) email Ryan.Ferry@dla.mil for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is May of 2019. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Attachments
Notice history
| Notice | Type | Posted |
|---|---|---|
| Methylphenidate HCL ER Tablets | Award Notice | |
| Methylphenidate HCL ER | Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity